Wang Qunbin (Chinese: 汪群斌; born 1969) is a Chinese billionaire businessman. He was appointed co-chairman of Fosun International in February 2020, and was CEO of Fosun from March 2017 to February 2020, when he replaced Liang Xinjun. He earned a bachelor's degree in genetic engineering from Fudan University, Shanghai in 1991.
Wang Qunbin - Wikipedia
https://en.wikipedia.org/wiki/Wang_QunbinWeb results:
Wang Qunbin (Chinese: 汪群斌; born 1969) is a Chinese billionaire businessman. He was appointed co-chairman of Fosun International in February 2020, and was CEO of Fosun from March 2017 to February 2020, when he replaced Liang Xinjun. He earned a bachelor's degree in genetic engineering from Fudan University, Shanghai in 1991.
Wang Qunbin is one of four co-founders and the president of Fosun Group, a diversified investment company headquartered in Shanghai. Wang holds a degree in genetic engineering from Fudan...
Wang Qunbin. Executive Director and Co-Chairman of Fosun International. Wang Qunbin, aged 52, is an Executive Director and Co-Chairman of the Company, and the founder of the Group. Mr. Wang was a non-executive director of Fosun Pharma (listed on the Hong Kong Stock Exchange and the SSE) and Sinopharm (listed on the Hong Kong Stock Exchange).
Wang Qunbin joined Guo Guangchang as co-chairman in early 2020. The company is located in 16 countries and is one of the largest privately owned conglomerates in China. It was ranked 371st on the Forbes Global 2000 ranking in 2020.
The group has appointed Wang Qunbin, its current chief executive officer, to be co-chairman with the company’s billionaire founder Guo Guangchang, it said in a stock exchange filing on Friday....
WANG Qunbin. Executive Director and Co-Chairman of Fosun International. Wang Qunbin, aged 52, is an Executive Director and Co-Chairman of the Company, and the founder of the Group. Mr. Wang was a non-executive director of Fosun Pharma (listed on the Hong Kong Stock Exchange and the SSE) and Sinopharm (listed on the Hong Kong Stock Exchange).
Wang Qunbin is an Executive Director and Co-Chairman of Fosun International, and the founder of the Group. Wang Qunbin was appointed as a Director of the Company on May 1995. Wang served as the Company’s Director and general manager from 1995 to 2007 and was the chairman of the Board of the Company from October 2007 to June 2010.He served as CEO
Wang Qunbin is a Chinese billionaire businessman. He was appointed co-chairman of Fosun International in February 2020, and was CEO of Fosun from March 2017 to February 2020, when he replaced Liang Xinjun.[2]
Mr. Wang Qunbin is a Non-Executive Director and Board Committee member of Peak Re. He is one of the founders of Fosun and a Director of Yuyuan and is a Non-Executive Director of Sinopharm and Fosun Pharma.
Mr. Qunbin Wang is a Co-Founder and serves as Co-Chairman & Executive Director at Fosun International. He serves as Board Member at Peak Reinsurance Company. He is also a Director of Yuyuana Non-executive Director of Sinopharm (HKEx stock code: 01099) and Fosun Pharma. He was appointed as the Co-Chairman of Fosun in February 2020. Mr.